Arbor, a telehealth platform for compounded GLP-1 medications, announced today that it will lock prices for life and back new patients with a 12-month money-back guarantee. The move lands the same week Kentucky Medicaid rules are shown to be blocking a federal program that could have cut GLP-1 costs for residents there, and a reminder from a weight-loss expert that stopping these drugs can undo the progress they helped create. One reader's story of losing eight stone without ever touching Mounjaro or Wegovy adds another angle entirely.
The lifetime price lock is the central feature of Arbor's offer. Arbor is telling patients that whatever rate they lock in when they start treatment stays fixed for as long as they remain on the plan, through its telehealth platform for compounded GLP-1 medications. The 12-month money-back guarantee adds a second layer of protection, giving new patients a full year to decide whether the medication is working for them before they are locked into a plan they regret. For patients comparing options, that combination of a guaranteed price and a refund window may be worth weighing against other telehealth providers.
That price lock starts at $99 per month for compounded semaglutide and tirzepatide plans, according to Arbor's program details. Patients connect with licensed providers online who review their eligibility before prescribing either medication, a process similar to other telehealth weight-loss platforms already on the market. The final monthly cost will still depend on the specific plan and dose a provider recommends, so the $99 starting rate should be treated as a floor rather than a guaranteed price for every patient. Anyone considering the offer should confirm exactly what is included in that starting rate before committing to a full year of treatment.
Cost is also the sticking point in Kentucky, where a federal Medicare program could in theory bring down what some patients pay for GLP-1 drugs. The problem is that Kentucky's Medicaid rules were not written with this kind of coverage in mind, and those older rules are currently standing in the way of residents who would otherwise benefit. The gap points to a familiar pattern, where federal programs move to expand access but state-level rules take time to catch up. Until Kentucky updates its Medicaid framework, patients there will need to look at private options, including telehealth platforms, if they want a lower monthly cost.
Price is one part of the GLP-1 decision, and what happens after treatment is another. A patient recently asked an expert a direct question: if they stop taking the medication, will they lose the progress they made? The expert's answer was straightforward. Stopping a GLP-1 medication can lead to regaining the weight that was lost while on it, because the drug's effect on appetite and metabolism does not necessarily carry over once treatment ends. That answer is worth weighing alongside any pricing offer, since a lower monthly cost still means committing to treatment for the long term if the goal is to keep the weight off.
Not every weight-loss result comes from a GLP-1 medication, though. One person shared that they lost eight stone and reached what they describe as the best shape of their life without ever using Mounjaro or Wegovy. Their story stands as a reminder that these medications are one path among several, not the only route to significant weight loss. For readers weighing whether a GLP-1 plan is worth the cost, it may help to remember that non-drug approaches remain part of the picture too.
For readers shopping for compounded GLP-1 plans, the practical takeaway is to read the terms behind any lifetime price lock or money-back guarantee before signing up, and to ask what the monthly rate will actually cover as doses change. It also helps to think past the first year of treatment, considering what happens if you stop and whether you have a plan for maintaining results either way. If you're in Kentucky and hoping a federal program will lower your GLP-1 costs, it is worth contacting your Medicaid office directly to ask when state rules might change. Whatever path you choose, the medication is a tool, not the only route to reaching your goal.
Key details
Arbor locks GLP-1 prices for life and offers a 12-month money-back guarantee.
Compounded semaglutide and tirzepatide plans through Arbor start at $99 per month.
A federal Medicare program could cut GLP-1 costs, but Kentucky's Medicaid rules block it.
Stopping a GLP-1 medication may lead to regaining lost weight, according to an expert.
One person lost eight stone and reached their best shape without using Mounjaro or Wegovy.
Originally published on GLP-1 Nation.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.